Rafal Krygier

head

Poland

Research Interests

Explore related searches

Professors in Poland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (13)

Joanna Musialik

Assistant Professor

Medical University of Silesia

POLAND

View details

Malgorzata Pawlowska

Professor

Nicolaus Copernicus University

POLAND

View details

Brygida Knysz

professor

Wroclaw Medical University

POLAND

View details

Robert Flisiak

Medical University of Białystok

POLAND

View details

Ewa Janczewska

Medical University of Silesia

POLAND

View details

Kaja Mielczak

Pomeranian Medical University

POLAND

View details

Brygida Adamek

Medical University of Silesia

POLAND

View details

Barbara Sobala-Szczygiel

Medical University of Silesia

POLAND

View details

Krzysztof Simon

MD,PhD.Prof; Head of the Department

Medical University of Silesia

POLAND

View details

Anna Piekarska

Proff

Medical University of Lodz

POLAND

View details

Piotr Stępień

Jan Kochanowski University

POLAND

View details

Jerzy Jaroszewicz

Medical University of Silesia

POLAND

View details

Wlodzimierz Mazur

Medical University of Silesia

POLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Rafal Krygier

Research Interests

Explore related searches

Contact this professor

Articles (10)

Rescue Therapy after Failure of HCV Antiviral Treatment with Interferon-Free Regimens

Does a detectable HCV RNA at the end of DAA therapy herald treatment failure?

Hepatitis C Infection as a Risk Factor for Hypertension and Cardiovascular Diseases: An EpiTer Multicenter Study

HCV Genotype Has No Influence on the Incidence of Diabetes—EpiTer Multicentre Study

Pangenotypic and Genotype-Specific Antivirals in the Treatment of HCV Genotype 4 Infected Patients with HCV Monoinfection and HIV/HCV Coinfection

Best therapy for the easiest to treat hepatitis C virus genotype 1b-infected patients.

Efficacy of 8- versus 12-week treatment with ledipasvir/sofosbuvir in chronic hepatitis C patients eligible for 8-week regimen in a real-world setting

Effectiveness and safety of pangenotypic regimens in the most difficult to treat population of genotype 3 HCV infected cirrhotics.

HCV resistance-associated substitutions following direct-acting antiviral therapy failure - Real-life data from Poland.

Factors influencing the failure of interferon-free therapy for chronic hepatitis C: Data from the Polish EpiTer-2 cohort study.

Collaborators (13)

Joanna Musialik

Malgorzata Pawlowska

Brygida Knysz

Robert Flisiak

Ewa Janczewska

Kaja Mielczak

Brygida Adamek

Barbara Sobala-Szczygiel

Krzysztof Simon

Anna Piekarska

Piotr Stępień

Jerzy Jaroszewicz

Wlodzimierz Mazur

Make your next move.